The FDA-approved prescribing information specifically indicates semaglutide is for subcutaneous use only
Additionally, for diabetic patients, the difficulty in managing blood sugar levels can lead to acute complications such as diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS), both of which can be fatal if not promptly treated
10.1089/ars.2011.4151 10 BannisterC
EU residents should verify whether FeelGood's telehealth services are available in their jurisdiction and confirm pricing, consumer protection rights, and cancellation terms before enrollment
Regular review : Monitoring data should be reviewed at routine appointments (typically 36 monthly) to assess treatment effectiveness, adjust therapy, and address any concerns
Khalid Danish et al., 2022)